Sanofi Halts Work On Its Covid Vaccine
The French company announced Tuesday that its shot produced neutralizing antibodies against the virus in early-stage clinical trials. However, it will not proceed with Phase 3 trials because the market is already well served, said Thomas Triomphe, head of Sanofi’s vaccine business.